Response to and outcomes of the Pfizer BNT162B2 vaccine in hemodialysis patients-A prospective observational study.
Abdullah Al-MuhaiteebAli AlSahowAnas Al-YousefBassam AlHelalHeba AlrajabYousif BahbahaniNoha DewidarGeorge N M FanousPublished in: Hemodialysis international. International Symposium on Home Hemodialysis (2022)
Seropositive patients with low antibody titer might be associated with worse outcome among responders. The ideal antibody titer level among dialysis patient is not known. Also, prior COVID-19 infection is associated with higher response to vaccine with higher antibody titer. All non-responders did not have prior COVID-19 infection. More research is required to further evaluated protective antibody titer.